Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy

Nephrology Dialysis Transplantation

Volumn 23, Issue 1, 2008, Pages 315-320

  Murakami, Reiichi ^a,c   Murakami, Shuichi ^a   Tsushima, Rumi ^a   Ueda, Chiyuki ^a   Mikami, Kyoko ^a   Ebina, Takanori ^a   Kumasaka, Ryuichiro ^b   Nakamura, Norio ^b   Okumura, Ken ^b  

^a Murakami Hospital   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^c Murakami Shinmachi Hospital   (Japan)

Author keywords

Diabetes mellitus (DM); Intact PTH; Renal osteodystrophy

Indexed keywords

HEMOGLOBIN A1C; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CHRONIC GLOMERULONEPHRITIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEODYSTROPHY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; BLOOD; COHORT ANALYSIS; GLUCOSE BLOOD LEVEL; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

BLOOD GLUCOSE; COHORT STUDIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 44449111249     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm639     Document Type: Article

References (20)

1. Nakai S, Shinzato T, Nagura Y et al. An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial 2004; 8: 3-32
2. Vincenti F, Hattner R, Amend WJ Jr et al. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. JAMA 1981; 245: 930-933
3. Inaba M, Okuno S, Nagasue K et al. Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients. Am J Kidney Dis 2001; 38: S139-S142
4. Inaba M, Nagasue K, Okuno S et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 2002; 39: 1261-1269
5. Nishitani H, Miki T, Morii H et al. Decreased bone mineral density in diabetic patients on hemodialysis. Contrib Nephrol 1991; 90: 223-227
6. Pei Y, Hercz G, Greenwood C et al. Renal osteodystrophy in diabetic patients. Kidney Int 1993; 44: 159-164
7. Holgado R, Haire H, Ross D et al. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis. J Bone Miner Res 2000; 15: 927-935
8. Sugimoto T, Ritter C, Morrissey J et al. Effects of high concentrations of glucose on PTH secretion in parathyroid cells. Kidney Int 1990; 37: 1522-1527
9. Martinez I, Saracho R, Moina I et al. Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure? Nephrol Dial Transplant 1998; 13: S9-S11
10. Goodman WG, Juppner H, Salusky IB et al. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 2003; 63: 1-11
11. Urena P, Hruby M, Ferreira A et al. Plasma total versus bone alkaline phosphatase as marker of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996; 7: 506-512
12. Morishita T, Nomura M, Hanaoka M et al. A new assay method that detects only intact osteocalcin. Two-step non-invasive diagnosis to predict adynamic bone disease in haemodialized patients. Nephrol Dial Transplant 2000; 15: 659-667
13. Krakauer JC, McKenna MJ, Buderer NF et al. Bone loss and bone turnover in diabetes. Diabetes 1995; 44: 775-782
14. Sayinalp S, Gedik O, Koray Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcif Tissue Int 1995; 57: 422-425
15. Inaba M, Nishizawa Y, Mita K et al. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 1999; 9: 525-531
16. Thalassinos NC, Hadjiyanni P, Tzanela M et al. Calcium metabolism in diabetes mellitus: effect of improved blood glucose control. Diabet Med 1992; 10: 341-344
17. Nagasaka S, Murakami T, Uchikawa T et al. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocr J 1995; 42: 377-383
18. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-842
19. Takagi M, Kasayama S, Yamamoto T et al. Advanced glycation end-products stimulates interleukin-6 production by human bone-derived cells. J Bone Miner Res 1997; 12: 439-446
20. Yamamoto T, Ozono K, Miyauchi A et al. Role of advanced glycation endproducts in adynamic bone disease in patients with diabetic nephropathy. Am J Kidney Dis 2001; 38: S161-S164